Does IXEKIZUMAB Cause Dermatitis? 27 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Dermatitis have been filed in association with IXEKIZUMAB (TALTZ). This represents 0.1% of all adverse event reports for IXEKIZUMAB.
27
Reports of Dermatitis with IXEKIZUMAB
0.1%
of all IXEKIZUMAB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Dermatitis From IXEKIZUMAB?
Of the 27 reports, 2 (7.4%) required hospitalization, and 1 (3.7%) were considered life-threatening.
Is Dermatitis Listed in the Official Label?
Yes, Dermatitis is listed as a known adverse reaction in the official FDA drug label for IXEKIZUMAB.
What Other Side Effects Does IXEKIZUMAB Cause?
Injection site pain (3,799)
Psoriasis (2,818)
Drug ineffective (2,759)
Injection site erythema (2,144)
Injection site reaction (1,701)
Injection site swelling (1,615)
Incorrect dose administered (1,032)
Covid-19 (861)
Product dose omission issue (832)
Therapy interrupted (796)
What Other Drugs Cause Dermatitis?
DUPILUMAB (3,823)
ADAPALENE (2,088)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (1,615)
ADALIMUMAB (530)
METHOTREXATE (452)
ETANERCEPT (317)
SECUKINUMAB (294)
INFLIXIMAB (268)
NIVOLUMAB (251)
DENOSUMAB (246)
Which IXEKIZUMAB Alternatives Have Lower Dermatitis Risk?
IXEKIZUMAB vs JAKAFI
IXEKIZUMAB vs JANUMET
IXEKIZUMAB vs JANUVIA
IXEKIZUMAB vs JETREA
IXEKIZUMAB vs JUXTAPID